Physician

Marion Eunice Berbano Tamesis, M.D.

According to 2025 Medicare claims, Marion Tamesis, M.D. (NPI: 1821022344) practices dermatology in the Binghamton, NY market, with the plurality of this provider's patient population coming from Broome, NY. This provider's primary affiliated billing organization is NEW SEASON DERMATOLOGY, PLLC (NPI: 1992215180; TIN: 822262775) and primary practice location at 13790-1308. Tamesis is affiliated with the Keystone ACO (ACO ID: A1552), participating under the MSSP model.

Tamesis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 424 traditional Medicare patients, billed 2,724 HCPCS/CPT codes, and received $132,791 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 933 prescription claims across 393 beneficiaries totaling $305,152 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 68 records totaling $1,301. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $12,812 to $305,152. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$121K$241K2017 Medicare payment: $71,051 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $168,089 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $210,953 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $224,863 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $241,285 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $208,146 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $95,779 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $132,791 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
20172811,300$71,051
20185993,468$168,089
20198094,312$210,953
20208324,697$224,863
20218934,748$241,285
20228375,283$208,146
20233452,030$95,779
20244242,724$132,791

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$242K$484K2015 Drug cost: $12,812 (USD; Tot_Drug_Cst)2016 Drug cost: $18,632 (USD; Tot_Drug_Cst)2017 Drug cost: $27,818 (USD; Tot_Drug_Cst)2018 Drug cost: $157,409 (USD; Tot_Drug_Cst)2019 Drug cost: $253,838 (USD; Tot_Drug_Cst)2020 Drug cost: $335,821 (USD; Tot_Drug_Cst)2021 Drug cost: $438,961 (USD; Tot_Drug_Cst)2022 Drug cost: $483,674 (USD; Tot_Drug_Cst)2023 Drug cost: $341,548 (USD; Tot_Drug_Cst)2024 Drug cost: $305,152 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201546116$12,812
201644156$18,632
2017142312$27,818
2018281751$157,409
2019379960$253,838
20204121,148$335,821
20215011,214$438,961
20225151,362$483,674
2023334806$341,548
2024393933$305,152

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more238382$85
17110Destruction of skin growth, 1-14 growths121148$77
11102Biopsy of related skin growth, first growth145161$57
17000Destruction of precancer skin growth, 1 growth206277$37
17003Destruction of precancer skin growth, 2-14 growths150976$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab12392$51,967
Clobetasol PropionateClobetasol Propionate1454,162$4,860
FluorouracilFluorouracil30728$1,983
ImiquimodImiquimod321,125$1,913
MetronidazoleMetronidazole29792$1,646

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.68$1,301ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Marion Eunice Berbano Tamesis, M.D.?

Tedicare shows public-source Medicare data for Marion Eunice Berbano Tamesis, M.D. (NPI 1821022344), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Marion Eunice Berbano Tamesis, M.D. have ACO affiliation data?

Marion Eunice Berbano Tamesis, M.D. is shown with ACO affiliation data for Keystone ACO (MSSP, ACO ID A1552).

What billing organization is linked to Marion Eunice Berbano Tamesis, M.D.?

Marion Eunice Berbano Tamesis, M.D. is linked to NEW SEASON DERMATOLOGY, PLLC (billing NPI 1992215180) in the available physician profile data.

Does Marion Eunice Berbano Tamesis, M.D. have Open Payments data?

Marion Eunice Berbano Tamesis, M.D. has 68 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.